These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6264937)
1. The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentration. Feely J; Crooks J; Stevenson IH Br J Clin Pharmacol; 1981 Jul; 12(1):73-8. PubMed ID: 6264937 [TBL] [Abstract][Full Text] [Related]
2. Plasma propranolol steady state concentrations in thyroid disorders. Feely J; Crooks J; Stevenson IH Eur J Clin Pharmacol; 1981; 19(5):329-33. PubMed ID: 7238561 [TBL] [Abstract][Full Text] [Related]
3. Plasma protein binding of propranolol and isoprenaline in hyperthyroidism and hypothyroidism. Kelly JG; McDevitt DG Br J Clin Pharmacol; 1978 Aug; 6(2):123-7. PubMed ID: 678388 [TBL] [Abstract][Full Text] [Related]
4. Altered plasma protein binding of drugs in thyroid disease. Feely J; Stevenson IH; Crooks J Clin Pharmacokinet; 1981; 6(4):298-305. PubMed ID: 7249488 [TBL] [Abstract][Full Text] [Related]
5. Influence of surgery on plasma propranolol levels and protein binding. Feely J; Forrest A; Gunn A; Hamilton W; Stevenson I; Crooks J Clin Pharmacol Ther; 1980 Dec; 28(6):759-64. PubMed ID: 7438691 [TBL] [Abstract][Full Text] [Related]
6. Increased clearance of propranolol in thyrotoxicosis. Feely J; Stevenson IH; Crooks J Ann Intern Med; 1981 Apr; 94(4 pt 1):472-4. PubMed ID: 7212504 [TBL] [Abstract][Full Text] [Related]
7. Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol. Hallengren B; Nilsson OR; Karlberg BE; Melander A; Tegler L; Wåhlin-Boll E Eur J Clin Pharmacol; 1982; 21(5):379-84. PubMed ID: 7075643 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of propranolol in healthy cats during euthyroid and hyperthyroid states. Jacobs G; Whittem T; Sams R; Calvert C; Ferguson D Am J Vet Res; 1997 Apr; 58(4):398-403. PubMed ID: 9099387 [TBL] [Abstract][Full Text] [Related]
10. Effect of propranolol on the plasma cyclic AMP and cyclic GMP levels to massive doses of glucagon in euthyroid and hyperthyroid subjects. Földes J; Gyertyánfy G; Piroska E; Juhász J Acta Med Acad Sci Hung; 1977; 34(4):227-34. PubMed ID: 218419 [TBL] [Abstract][Full Text] [Related]
11. The effect of age and hyperthyroidism on plasma propranolol steady state concentration [proceedings]. Feely J; Stevenson IH Br J Clin Pharmacol; 1978 Nov; 6(5):446P. PubMed ID: 728296 [No Abstract] [Full Text] [Related]
12. Age and beta-adrenergic receptor sensitivity to S(-)- and R,S(+/-)-propranolol in humans. Colangelo PM; Blouin RA; Steinmetz JE; McNamara PJ; DeMaria AN; Wedlund PJ Clin Pharmacol Ther; 1992 May; 51(5):549-54. PubMed ID: 1316824 [TBL] [Abstract][Full Text] [Related]
13. No enhanced elimination of propranolol in patients with hyperthyroidism. Ishizaki T; Masuno M; Tawara K Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):473-85. PubMed ID: 7423023 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of propranolol and sotalol in hyperthyroidism. Aro A; Anttila M; Korhonen T; Sundquist H Eur J Clin Pharmacol; 1982; 21(5):373-7. PubMed ID: 7075642 [TBL] [Abstract][Full Text] [Related]
15. Regulation of ketonaemia in hyperthyroidism: study of the role of free fatty acids. Beylot M; Cohen R; Riou JP; Sautot G; Garcia I; Noel G; Mornex R Diabete Metab; 1983 Sep; 9(3):217-23. PubMed ID: 6360743 [TBL] [Abstract][Full Text] [Related]
16. [Absence of effect of propranolol on urinary excretion of 3-methylhistidine in hyperthyroidism]. Beylot M; Riou JP; Sautot G; Mornex R Presse Med; 1984 Sep 1-8; 13(30):1829-31. PubMed ID: 6236442 [TBL] [Abstract][Full Text] [Related]